Janet Hampton Describes the Distress Thermometer

May 23, 2011

Janet Hampton, RN, BS

Janet Hampton Describes the Distress Thermometer

Janet Hampton, RN, BS, OCN® from the University of Michigan Health System Cancer Center Describes the Distress Thermometer

Related Videos

Guillermo Garcia-Manero, MD

Amer Zeidan, MBBS

Michael K. Gibson MD, PhD

Colin E. Champ, MD

Shilpa Gupta, MD

Samer A. Srour, MB ChB, MS

Adam D. Cohen, MD, director, Myeloma Immunotherapy, associate professor in medicine, hematology/oncology, Abramson Cancer Center, University of Pennsylvania

Alexandra Sokolova, MD

Christie J. Hilton, DO

Yuan Yuan, MD, PhD

Related Content

Zanidatamab Elicits Responses in HER2-amplified Advanced Biliary Tract Cancer

D'Amato Discusses Research and Resistance Mechanisms in Sarcoma and Gastrointestinal Stromal Tumor

February 9th 2023

HIMALAYA Safety Data Support STRIDE Regimen as A Global Treatment Option for uHCC

Acuna Discusses US Liver Cancer Incidence in Individuals of Mexican Descent

December 12th 2022

STAT2 Expression Is Higher in African American, Asian Patients With HCC

Liver Cancer Awareness Higher in Individuals Who Receive HBV/HCV Screening

Zanidatamab Elicits Responses in HER2-amplified Advanced Biliary Tract Cancer

D'Amato Discusses Research and Resistance Mechanisms in Sarcoma and Gastrointestinal Stromal Tumor

February 9th 2023

HIMALAYA Safety Data Support STRIDE Regimen as A Global Treatment Option for uHCC

Acuna Discusses US Liver Cancer Incidence in Individuals of Mexican Descent

December 12th 2022

STAT2 Expression Is Higher in African American, Asian Patients With HCC

Liver Cancer Awareness Higher in Individuals Who Receive HBV/HCV Screening

Zanidatamab Elicits Responses in HER2-amplified Advanced Biliary Tract Cancer

D'Amato Discusses Research and Resistance Mechanisms in Sarcoma and Gastrointestinal Stromal Tumor

February 9th 2023

HIMALAYA Safety Data Support STRIDE Regimen as A Global Treatment Option for uHCC

Acuna Discusses US Liver Cancer Incidence in Individuals of Mexican Descent

December 12th 2022

STAT2 Expression Is Higher in African American, Asian Patients With HCC

Liver Cancer Awareness Higher in Individuals Who Receive HBV/HCV Screening

Related Content

Shubham Pant, MD, MBBS

Zanidatamab Elicits Responses in HER2-amplified Advanced Biliary Tract Cancer

Gina Z. D’Amato, MD

D'Amato Discusses Research and Resistance Mechanisms in Sarcoma and Gastrointestinal Stromal Tumor

February 9th 2023

George Lau, MD, FRCP, FAASLD

HIMALAYA Safety Data Support STRIDE Regimen as A Global Treatment Option for uHCC

Nicholas Acuna, MPH

Acuna Discusses US Liver Cancer Incidence in Individuals of Mexican Descent

December 12th 2022

STAT2 Expression Is Higher in African American, Asian Patients With HCC

STAT2 Expression Is Higher in African American, Asian Patients With HCC

Liver Cancer

Liver Cancer Awareness Higher in Individuals Who Receive HBV/HCV Screening

Latest Conference Coverage

Efficacy of CLDN6-Directed CAR T Therapy Is Maintained With Automated Manufacturing in Solid Tumors

Subsequent Treatments Feasible After Radium-223 in mCRPC

Belzutifan/Lenvatinib Elicits Responses in Advanced ccRCC After Progression on Checkpoint Inhibitor and VEGF TKI

Talazoparib Plus Enzalutamide Has Manageble Toxicity With Dose Modifications, Supportive Care in mCRPC

View More Latest Conference Coverage

Editorial Board

CancerNetwork.com

OncNursingNews.com

TargetedOnc.com

Terms & Conditions

Do Not Sell My Information

Contact Info

2 Clarke Drive
Cranbury, NJ 08512

© 2023 MJH Life Sciences

All rights reserved.